| Literature DB >> 18612626 |
C Toso1, J A Emamaullee, S Merani, A M J Shapiro.
Abstract
Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine involved in many inflammatory reactions and disorders, and it has become evident that it also affects glucose homeostasis. The protein is produced by pancreatic beta cells and can promote the release of insulin. It also modulates glucose uptake, glycolysis and insulin resistance in insulin target cells such as the adipocyte, myocyte and cardiomyocyte. Possessing both immunological and endocrinological properties, MIF has been associated with the development of type 1 and type 2 diabetes, and it may be important in the setting of islet transplantation. The present review summarises our current knowledge, based on clinical and research data, on the impact of MIF on both physiological and pathological aspects of glucose metabolism.Entities:
Mesh：
Substances：
Year: 2008 PMID： 18612626 DOI： 10.1007/s00125-008-1063-3
Source DB: PubMed Journal: Diabetologia ISSN： 0012-186X Impact factor: 10.122